We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Okyo Pharma Limited | LSE:OKYO | London | Ordinary Share | GG00BD3FV870 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 91.00 | 1.20 | 1.60 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMOKYO
RNS Number : 5622G
OKYO Pharma Corporation
02 March 2018
For immediate release
2 March 2018
Okyo Pharma Corporation
("Okyo" or the "Company")
Change of Broker
The Company notes the announcement today regarding Beaufort Securities Limited ("BSL") and Beaufort Asset Clearing Services Limited ("BACSL") being placed into insolvency and that the Financial Conduct Authority (the "FCA") has imposed requirements on BSL and BACSL to cease all regulatory activity.
BSL is the broker to the Company pursuant to the AIM Rules for Companies (the "AIM Rules"). As a result of the requirements imposed by the FCA, BSL will no longer be able to provide broking services to the Company in accordance with the AIM Rules.
The Company is seeking to appoint a new broker as soon as possible and a further announcement will be made when this appointment is made.
This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse.
Enquiries:
Hot Features
Premium
Okyo Pharma Willy Simon, Chariman wsimon@okyopharma.com
Corporation
Michael Cornish
Beaumont Cornish Roland Cornish +44 (0)207628 3369
Email: corpfin@b-cornish.co.uk
ENDS
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPFKBDQBBKDPNK
(END) Dow Jones Newswires
March 02, 2018 07:47 ET (12:47 GMT)
1 Year Okyo Pharma Chart |
1 Month Okyo Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
